Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Tan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Diabetologia|July 2, 2005
Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapyG D Tan, C Debard, T Funahashi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 3, 2017
Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospitalT Marjot, E Sbardella, A Moolla, et al.
Diabetologia|December 20, 2005
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford BiobankG D Tan, M J Neville, E Liverani, et al.
Diabetologia|December 25, 2004
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetesG D Tan, B A Fielding, J M Currie, et al.
Diabetologia|January 24, 2007
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetesT Cadoudal, J M Blouin, M Collinet, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Diabetologia|July 2, 2005
Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapyG D Tan, C Debard, T Funahashi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 3, 2017
Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospitalT Marjot, E Sbardella, A Moolla, et al.
Diabetologia|December 20, 2005
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford BiobankG D Tan, M J Neville, E Liverani, et al.
Diabetologia|December 25, 2004
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetesG D Tan, B A Fielding, J M Currie, et al.
Diabetologia|January 24, 2007
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetesT Cadoudal, J M Blouin, M Collinet, et al.
Pageof 2